Subsequent Primary Malignancies Among Myelodysplastic Syndrome Patients Treated with or without Lenalidomide

被引：0
|
作者：
Rollison, Dana E. [1 ]
Shain, Kenneth H. [1 ]
Lee, Ji-Hyun [2 ]
Hampras, Shalaka S. [1 ]
Fisher, Kate [1 ]
Al Ali, Najla H. [1 ]
Padron, Eric [3 ]
Lancet, Jeff E. [1 ]
Olesnyckyj, Marta [4 ]
Kenvin, Laurie [4 ]
Knight, Robert D. [4 ]
Dalton, William [1 ]
List, Alan F. [1 ]
Komrokji, Rami [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[2] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA
[3] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[4] Celgene Corp, Summit, NJ USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis
    Dispenzieri, Angela
    Lacy, Martha Q.
    Zeldenrust, Steven R.
    Hayman, Suzanne R.
    Kumar, Shaji K.
    Geyer, Susan M.
    Lust, John A.
    Allred, Jacob B.
    Witzig, Thomas E.
    Rajkumar, S. Vincent
    Greipp, Philip R.
    Russell, Stephen J.
    Kabat, Brian
    Gertz, Morie A.
    BLOOD, 2007, 109 (02) : 465 - 470
  • [42] Microarray-based miRNA expression profiling in patients with myelodysplastic syndrome with deletion of chromosome 5q treated with lenalidomide
    Krejcik, Z.
    Merkerova, M. Dostalova
    Belickova, M.
    Mrhalkova, A.
    Klema, J.
    Stara, E.
    Zemanova, Z.
    Brezinova, D.
    Cermak, J.
    Jonasova, A.
    LEUKEMIA RESEARCH, 2013, 37 : S29 - S29
  • [43] MALIGNANCIES IN PATIENTS WITH PRIMARY SJOGREN'S SYNDROME
    Isik, O. Ozdemir
    Yazici, A.
    Cefle, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1514 - 1514
  • [44] Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab
    Casneuf, Tineke
    Adams, Homer C., III
    van de Donk, Niels W. C. J.
    Abraham, Yann
    Bald, Jaime
    Vanhoof, Greet
    Van der Borght, Koen
    Smets, Tina
    Foulk, Brad
    Nielsen, Karl C.
    Rusbuldt, Joshua
    Axel, Amy
    Lysaght, Andrew
    Ceulemans, Hugo
    Stevenaert, Frederik
    Usmani, Saad Z.
    Plesner, Torben
    Avet-Loiseau, Herve
    Nijhof, Inger
    Mutis, Tuna
    Schecter, Jordan M.
    Chiu, Christopher
    Bahlis, Nizar J.
    LEUKEMIA, 2021, 35 (02) : 573 - 584
  • [45] Metabolic Syndrome Among Patients with Myelodysplastic Syndrome: A Population Analysis
    Batra, Akshee
    Sparks, Andrew
    Singh, Rohit
    Khosla, Atulya Aman
    Zakai, Neil
    Herrera, Diego Adrianzen
    BLOOD, 2023, 142
  • [46] Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab
    Tineke Casneuf
    Homer C. Adams
    Niels W.C.J. van de Donk
    Yann Abraham
    Jaime Bald
    Greet Vanhoof
    Koen Van der Borght
    Tina Smets
    Brad Foulk
    Karl C. Nielsen
    Joshua Rusbuldt
    Amy Axel
    Andrew Lysaght
    Hugo Ceulemans
    Frederik Stevenaert
    Saad Z. Usmani
    Torben Plesner
    Herve Avet-Loiseau
    Inger Nijhof
    Tuna Mutis
    Jordan M. Schecter
    Christopher Chiu
    Nizar J. Bahlis
    Leukemia, 2021, 35 : 573 - 584
  • [47] Second primary malignancies among cancer patients
    Zheng, Xuanqi
    Li, Xiao
    Wang, Minqi
    Shen, Jianfei
    Sisti, Giovanni
    He, Zelai
    Huang, Jinfeng
    Li, Yan Michael
    Wu, Aimin
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (10)
  • [48] Thyroid abnormalities in patients treated with lenalidomide for hematological malignancies: Results of a retrospective case review
    Figaro, M. Kathleen
    Clayton, Warren, Jr.
    Usoh, Chinenye
    Brown, Kara
    Kassim, Adetola
    Lakhani, Vipul T.
    Jagasia, Shubhada
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (06) : 467 - 470
  • [49] Results of phase II clinical study of lenalidomide in Japanese patients with myelodysplastic syndrome (MDS)
    Harada, H.
    Watanabe, M.
    Suzuki, K.
    Yanagita, S.
    Suzuki, T.
    Yoshida, Y.
    Kimura, A.
    Tsudo, M.
    Takatoku, M.
    Ozawa, K.
    LEUKEMIA RESEARCH, 2009, 33 : S123 - S123
  • [50] Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide
    Merkerova, Michaela Dostalova
    Krejcik, Zdenek
    Belickova, Monika
    Hrustincova, Andrea
    Klema, Jiri
    Stara, Eliska
    Zemanova, Zuzana
    Michalova, Kyra
    Cermak, Jaroslav
    Jonasova, Anna
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (01) : 35 - 43
12345